From a Forbes article in 2003...
Pharmaceuticals
Statin Makers Bet Big On Imaging Technique
ORLANDO, FLA. - Trying to get a leg up in the $22 billion market for cholesterol medicines, drug companies increasingly are turning to an imaging technique that allows researchers to see how much plaque is building inside arteries. Several of the biggest players are funding major research studies, and--in an unusual twist--many of these clinical trials are being run by the same cardiologist: Steven E. Nissen.
In retrospect, we realize that it is not unusual at all just...business as usual.
www.forbes.com/2003/11/10/cx_mh_1110merck.html
Pharmaceuticals
Statin Makers Bet Big On Imaging Technique
ORLANDO, FLA. - Trying to get a leg up in the $22 billion market for cholesterol medicines, drug companies increasingly are turning to an imaging technique that allows researchers to see how much plaque is building inside arteries. Several of the biggest players are funding major research studies, and--in an unusual twist--many of these clinical trials are being run by the same cardiologist: Steven E. Nissen.
In retrospect, we realize that it is not unusual at all just...business as usual.
www.forbes.com/2003/11/10/cx_mh_1110merck.html
